May 03, 2019
3 min watch
Save

VIDEO: Encapsulated cell therapy shows promising results in MacTel and glaucoma

SAN DIEGO  At the Ophthalmology Innovation Summit, Rich Small, CPA, CEO of Neurotech Pharmaceuticals, discusses the company’s encapsulated cell therapy’s progress in clinical trials for macular telangiectasia as well as neuroprotection in glaucoma.